Who bought out Walgreens Pharmacy?

Walgreens was bought out by the private equity firm Sycamore Partners in a roughly $10 billion deal that closed in August 2025, taking the company private and splitting it into five separate entities, including the retail pharmacy, Boots, VillageMD, CareCentrix, and Shields Health Solutions. Sycamore partnered with the Pessina family, who reinvested their stake, and appointed Mike Motz as the new CEO.

Did Walgreens pharmacy get bought out?

—Aug. 28, 2025—Walgreen Co. (“Walgreens”, or the “Company”), America's leading independent retail pharmacy, announced today that it is now operating as a private standalone company following its acquisition by Sycamore Partners (“Sycamore”), a leading private equity firm based in New York.

Who is Walgreens owned by now?

Walgreens was acquired by the private equity firm Sycamore Partners in a ~$10 billion deal that closed in August 2025, taking the company private and splitting it into five standalone businesses, including Walgreens, Boots, VillageMD, Shields Health Solutions, and CareCentrix. Sycamore Partners, in partnership with Stefano Pessina's family, aims to restructure Walgreens to focus on long-term improvements and address financial challenges. 

Why is Sycamore buying Walgreens?

Sycamore Partners bought Walgreens primarily because the struggling retailer needed a major financial turnaround, facing declining sales, plummeting pharmacy margins, and failed healthcare ventures, with the private equity firm offering expertise in retail restructuring and the chance to go private, removing pressure for short-term growth. Sycamore plans to split Walgreens into five separate companies for focused management and long-term improvements, leveraging their retail experience to navigate challenges and drive value. 

Who are Sycamore Partners owned by?

Sycamore Partners is a private equity firm, not owned by a single individual, but by its partners and investors, including endowments, pension funds, and family offices, with founders Stefan Kaluzny and Peter Morrow establishing it in 2011. It operates as a private entity, managing investments in consumer, retail, and distribution companies, focusing on operational improvements and strategic value. 

Why Walgreens And CVS Are Shutting Down Thousands Of Stores

Who is the new owner of Walgreens?

Walgreens' new ownership involves private equity firm Sycamore Partners acquiring Walgreens Boots Alliance in a $10+ billion deal that took the company private in August 2025, splitting it into five standalone entities: Walgreens (US retail), Boots (international), Shields Health Solutions, CareCentrix, and VillageMD, with a focus on restructuring and improving performance under a new CEO, Mike Motz, following significant financial challenges.
 

Why did Peter Morrow leave Sycamore Partners?

Peter Morrow, co-founder of Sycamore, left in 2022 for undisclosed reasons, Buyouts previously reported. Morrow joined Consello Group and is leading the firm's private equity effort, expected to raise its debut fund this year.

What caused Walgreens' downfall?

Walgreens is struggling due to a combination of declining prescription profits from Pharmacy Benefit Managers (PBMs), increased competition (Walmart, Costco), changing consumer habits, high debt, overexpansion, and operational issues like understaffing and theft, leading to lower retail sales and store closures despite pandemic-era vaccination boosts. Misguided health care acquisitions (VillageMD, Summit Health) also burdened finances, forcing a strategic pivot away from being a primary care provider to focusing on core pharmacy and virtual health, notes.
 

Who is the CEO of Sycamore Partners?

Stefan Kaluzny. Stefan Kaluzny has been the firm's founder and principal managing director since 2011. Prior to Sycamore Partners, Kaluzny was a managing director at Golden Gate Capital. Kaluzny was with Golden Gate Capital from its inception in 2000 until January 2011.

Who owns Walgreens today?

Walgreens was acquired by the private equity firm Sycamore Partners in a ~$10 billion deal that closed in August 2025, taking the company private and splitting it into five standalone businesses, including Walgreens, Boots, VillageMD, Shields Health Solutions, and CareCentrix. Sycamore Partners, in partnership with Stefano Pessina's family, aims to restructure Walgreens to focus on long-term improvements and address financial challenges. 

How much did Sycamore pay for Walgreens?

The companies announced the $10 billion deal in March. Sycamore agreed to pay $11.45 per share for the company, an equity value of about $10 billion, according to The Wall Street Journal. Walgreens said in a press release that accounting for debt and future payouts, the value could reach up to $23.7 billion.

Why are so many Walgreens shutting down?

Walgreens is closing stores due to a combination of financial struggles, overexpansion, and industry-wide pressures like low prescription reimbursement rates from Pharmacy Benefit Managers (PBMs), increased competition from online pharmacies and big-box retailers (Walmart, Target), high operating costs (staffing, theft), and shifts in consumer behavior, with CEO Tim Wentworth targeting unprofitable locations as part of a cost-cutting strategy. 

Who does Walgreens get their drugs from?

The Deerfield, Illinois-based company, which operates the Walgreens and Duane Reade pharmacies in the United States and Boots in Britain, has more than 18,750 stores in over 25 countries. It has an agreement to source branded and generic drugs from AmerisourceBergen in the United States.

Is Walgreens closing in 2025?

Walgreens is closing about 1,200 underperforming stores over three years, with approximately 500 slated for closure in its fiscal year 2025 (ending August 31, 2025) as part of a "Footprint Optimization Program" to cut costs and focus on core pharmacy services. Specific locations have closed throughout 2025 in states like California, Massachusetts, New Jersey, and Ohio, with pharmacies transferring prescriptions to nearby stores and offering delivery.
 

Is Walgreens owned by CVS?

As of August 2025, Walgreens is owned by private equity firm Sycamore Partners.

Is Walgreens laying off employees?

Around the same time in 2024, the pharmacy chain laid off around 256 corporate workers and announced its plans to shutter 1,200 stores. More corporate roles had been cut earlier that year.

Is Sycamore Partners a Chinese company?

Sycamore Partners is an American private equity firm based in New York specializing in retail and consumer investments. The firm has approximately $10 billion in aggregate committed capital.

What are the big 4 private equity firms?

The "Big 4" in private equity generally refers to the largest and most influential firms: Blackstone, KKR, The Carlyle Group, and Apollo Global Management, known for massive funds, leveraged buyouts, and significant market impact, though rankings shift with fundraising and AUM. Other top-tier firms consistently ranked high include EQT, Thoma Bravo, CVC, and TPG, specializing in software, technology, and various sectors.
 

Who is Sailesh Raj Bhan?

Sailesh Raj Bhan is President & CIO – Equity Investments at Nippon India Mutual Fund. He has over 27 years of experience in Indian Equity Markets with over 19years at Nippon Life India Asset Management Limited.

Who is bigger, CVS or Walgreens?

Yes, CVS is generally considered bigger than Walgreens, leading in both the number of retail locations and overall revenue, largely because CVS Health operates a more diversified healthcare business that includes a massive Pharmacy Benefit Manager (PBM) like Aetna, making its market share in prescription revenue significantly larger, though Walgreens has a very strong, comparable retail presence.
 

Is Walgreens in trouble financially?

Yes, Walgreens has faced significant financial troubles, marked by massive net losses, declining market value, and the closure of about 2,000 stores over the past decade, with plans to shutter 1,200 more as it struggles with healthcare investments, competition, and adapting to changing consumer habits. The company was taken private by private equity firm Sycamore Partners in late 2024 to help navigate these challenges, but faces ongoing headwinds despite some revenue growth and efforts to pivot its healthcare strategy. 

What is the Walgreens drug scandal?

Walgreens has agreed to pay up to $350 million in a settlement with the U.S. Department of Justice, who accused the pharmacy of illegally filling millions of prescriptions in the last decade for opioids and other controlled substances.

Is Sycamore a good company?

Work environment & culture — Employees at Sycamores appreciate the supportive and empathetic environment, highlighting great co-workers and supervisors. However, they also report a high turnover rate and stress due to unrealistic productivity expectations.

How much are Sycamore Partners worth?

The firm has approximately $11 billion in aggregate committed capital. Our strategy is to partner with management teams to improve the operating profitability and strategic value of their businesses.

How much will Walgreens shareholders get?

Deal terms and valuation.

Walgreens shareholders approved the $10 billion acquisition at a July 11 special meeting. Shareholders received $11.45 per share in cash, totaling about $9.9 billion based on Walgreens' 865 million outstanding shares.